This study is designed to assess how effective social media is in disseminating scientific knowledge to physiotherapists in Brazil. The trial will include physiotherapists who treat at least three patients weekly and regularly use Instagram and WhatsApp. Participants will be randomly assigned to one of two groups: the experimental group will receive scientific content through Instagram, while the control group will receive the same content via email. Both groups will engage with the material for 10 weeks. The scientific content covers seven key topics related to physiotherapy, such as musculoskeletal and sport rehabilitation, and will be tailored to clinical practice. For the Instagram group, content will be shared via posts, stories, and reels, while the email group will receive summaries and links to full articles. The study aims to evaluate the impact of these interventions on participants\' engagement with scientific content and its application to clinical practice. Key outcomes will include the effectiveness of knowledge dissemination, participant feedback on the audiovisual content, and qualitative insights from interviews. The study will follow a specific timeline, with reassessment three months after the intervention to gauge long-term effects. Data will be analyzed using both quantitative and qualitative methods, ensuring a comprehensive understanding of the intervention\'s reach and feasibility.
This protocol details a randomized, single-blind controlled trial to assess how effectively scientific content can be disseminated to Brazilian physiotherapists using social media (Instagram). The study will follow physiotherapists who treat at least three patients per week and use Instagram and WhatsApp regularly. These participants will be randomized into two groups: an experimental group receiving content via Instagram and a control group receiving the same information via email. The study will focus on seven areas relevant to physiotherapy practice, including musculoskeletal rehabilitation, cardiovascular care, and women's health. The content, developed using scientific articles, will be shared daily over 10 weeks. For the Instagram group, the content will be presented through various formats like posts, stories, and reels, with visually engaging elements to boost retention. The email group will receive daily summaries of the articles, similar to a journal-style format. To maintain participant engagement, both groups will receive weekly summaries, and participants will be assessed on how well they apply the scientific content in practice. The primary outcomes include the effectiveness of content dissemination, participant engagement, and knowledge retention, evaluated through surveys, interviews, and technical assessments. Qualitative interviews will explore participants' experiences, and the quality of the audiovisual materials used will be rated by participants. The trial will last for 10 weeks, followed by an additional week for reassessment and a three-month follow-up. Data will be analyzed quantitatively to measure the reach and effectiveness of the interventions, with feasibility analyzed using the RE-AIM framework. Qualitative data will be analyzed through thematic analysis, ensuring an in-depth understanding of the intervention's success. This study aims to offer insights into the best methods for delivering scientific knowledge to healthcare professionals via digital platforms.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
120
Participants in the experimental group will follow a scientific Instagram profile where content will be shared. The profile will remain open, allowing permanent access to all posts. To optimize Instagram\'s algorithm, we will use an existing active profile. Any control group participants already following the profile will be removed upon allocation. For each selected article, we will create three presentations using Instagram features like carousel images and short videos, shared as posts, stories, and reels. This strategy will provide content for 30 weeks of daily posts. Each post will feature visually appealing graphics to convey scientific information and support evidence-based practice (EBP) competencies.
The participant allocated to the control group will receive a different summary each day, along with a link to the full article. This strategy was chosen to replicate the approach used by scientific journals to disseminate new issues.
Federal University of Santa Maria
Santa Maria, Rio Grande do Sul, Brazil
Use of scientific information to make clinical decisions
Participants should indicate their level using a scale 0-10 points (0 = I do not use; 10 = I only make clinical decisions using the best available evidence)
Time frame: Baseline and the end of treatment at 10 weeks
Understanding of scientific information interpretation for application in clinical practice
Participants should indicate their level using a scale 0-10 points (0 = I do not understand; 10 = I have a complete understanding to apply scientific findings in clinical practice)
Time frame: Baseline and the end of treatment at 10 weeks
Motivation to search for scientific information that could support clinical decisions
Participants should indicate their level using a scale 0-10 points (0 = I have no motivation; 10 = I am completely motivated)
Time frame: Baseline and the end of treatment at 10 weeks
Importance of scientific information in making clinical decisions
Participants should indicate their level using a scale 0-10 points (0 = No importance; 10 = Extremely important)
Time frame: Baseline and the end of treatment at 10 weeks
Barriers to applying scientific findings
Participants will describe their barriers to applying scientific findings in clinical practice and the number of barriers reported will be considered for analysis
Time frame: Baseline and the end of treatment at 10 weeks
Evidence-Based Practice Questionnaire (EBPQ)
The EBPQ evaluates EBP competencies and has 24 items scored using a 7-point Likert scale (1-7 points); mean of the items will be used for analysis
Time frame: Baseline and the end of treatment at 10 weeks
Overcoming the reported barriers
Participants will be asked whether the program helped to overcome the reported barriers (yes or no answer)
Time frame: End of treatment at 10 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.